ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,714Medicare Part D Prescriptions Filled, Including Refills

Rank: 201 out of 682

$610K Total Retail Price of All Prescriptions

Rank: 238 out of 682

351 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 10,941 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 439 414 1 3
OMEPRAZOLE 390 366 2 5
LISINOPRIL 384 365 3 2
FUROSEMIDE 364 347 4 7
HYDROCODONE-ACETAMINOPHEN 351 299 S3 5 1
SIMVASTATIN 331 318 6 4
AMLODIPINE BESYLATE 315 279 7 6
SERTRALINE HCL 308 284 8 24
LOSARTAN POTASSIUM 287 285 9 20
CRESTOR 241 227 10 22
METOPROLOL TARTRATE 231 228 11 10
ATORVASTATIN CALCIUM 221 216 12 11
TRAMADOL HCL 202 201 13 26
WARFARIN SODIUM 201 181 14 13
POTASSIUM CHLORIDE 196 188 15 14
RANITIDINE HCL 189 171 16 28
GABAPENTIN 176 172 17 9
METOPROLOL SUCCINATE 167 140 18 16
DONEPEZIL HCL 167 167 18 30
DIOVAN 147 144 20 42
MELOXICAM 145 145 21 27
METFORMIN HCL 136 109 22 8
NAMENDA 127 120 23 41
INDAPAMIDE 109 109 24 224
LANTUS 107 97 25 55
PANTOPRAZOLE SODIUM 105 104 26 29
CARVEDILOL 105 105 26 23
ISOSORBIDE MONONITRATE ER 104 100 28 31
ESCITALOPRAM OXALATE 103 103 29 73
DIGOXIN 102 98 30 46
CITALOPRAM HBR 95 95 31 17
SINGULAIR 93 91 32 63
NEXIUM 92 84 33 19
ATENOLOL 91 77 34 18
MIRTAZAPINE 90 90 35 52
IBUPROFEN 83 71 36 79
TAMSULOSIN HCL 80 79 37 33
ZOLPIDEM TARTRATE 79 74 38 21
FINASTERIDE 77 66 39 131
SPIRONOLACTONE 75 72 40 64
VENLAFAXINE HCL ER 71 61 41 119
PHENYTOIN SODIUM EXTENDED 70 56 42 140
OXYCODONE-ACETAMINOPHEN 69 69 S2 43 120
CLOPIDOGREL 68 68 44 25
ALLOPURINOL 67 52 45 32
ALENDRONATE SODIUM 66 66 46 37
CIPROFLOXACIN HCL 62 59 47 58
TRAMADOL HCL-ACETAMINOPHEN 61 61 48 216
MONTELUKAST SODIUM 60 58 49 112
CEPHALEXIN 57 55 50 128
GLIPIZIDE 57 51 50 61
NAPROXEN 57 57 50 97
FENTANYL 56 56 S2 53 86
LIPITOR 56 53 53 92
DILTIAZEM 24HR CD 54 43 55 123
LIDODERM 53 53 56 134
SPIRIVA 53 53 56 49
CARBIDOPA-LEVODOPA 52 52 58 121
GLIPIZIDE ER 51 39 59 108
LEXAPRO 50 50 60 222
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.